Yoav Chelouche
Managing Partner @ Aviv Venture Capital
Yoav Chelouche is a Series A investor at Aviv Venture Capital focused on Sports and Medical. Yoav Chelouche has served on our board of directors since 2006. Chelouche has also served as one of our outside directors under the Israeli Companies Law since 2006. Chelouche has been Managing Partner of Aviv Venture Capital since August 2000. Prior to joining Aviv Venture Capital, Chelouche served as President and Chief Executive Officer ofScitex Corp., a world leader in digital imaging and printing systems, from December 1994 until July 2000. From August 1979 until December 1994, Chelouche held various managerial positions with Scitex, including VP Strategy and Business Development, VP Marketing and VP Finance for Europe. Chelouche is the Chairman of the Board of Rosetta Genomics Ltd., and a member of the board of directors of a number of private companies. He is also Chairman of Taasiyeda, an Israeli nonprofit organization that promotes the development of leadership and technology skills in children. Chelouche earned a B.A. in Economics and Statistics from Tel Aviv University, and a M.B.A. from INSEAD University in Fontainebleau, France.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Yoav Chelouche invests in
Stages Yoav Chelouche invests in
Countries Yoav Chelouche invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Sports 1 (50%)
- Medical 1 (50%)
- Wellness 1 (50%)
- Health Care 1 (50%)
- Therapeutics 1 (50%)
Stage
- Series A 1 (50%)
- Funding Round 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| We at AposHealth® are passionate about revolutionizing the treatment of musculoskeletal conditions by simply addressing peoples’ gait to help alleviate pain and help them move better and live better. Our flagship solution, Apos®, is FDA-cleared to temporarily reduce knee pain caused by osteoarthritis. It can also be used as a general wellnessdevice to help patients live well with chronic lower back and hip pain. With a 96 percent satisfaction rate, over 110,000 patients treated, and dozens of peer-reviewed publications supporting the science behind Apos® as well as its clinical effect, this system—consisting of gait analysis, personalized foot-worn device, and a customized treatment plan—has helped patients with chronic knee, lower back, and hip pain worldwide move, live, and thrive. | $15M / Nov 25, 2014 | ||
| We at AposHealth® are passionate about revolutionizing the treatment of musculoskeletal conditions by simply addressing peoples’ gait to help alleviate pain and help them move better and live better. Our flagship solution, Apos®, is FDA-cleared to temporarily reduce knee pain caused by osteoarthritis. It can also be used as a general wellnessdevice to help patients live well with chronic lower back and hip pain. With a 96 percent satisfaction rate, over 110,000 patients treated, and dozens of peer-reviewed publications supporting the science behind Apos® as well as its clinical effect, this system—consisting of gait analysis, personalized foot-worn device, and a customized treatment plan—has helped patients with chronic knee, lower back, and hip pain worldwide move, live, and thrive. | $11M / Series A / Dec 01, 2011 |
About Aviv Venture Capital
Aviv Venture Capital is a private equity and venture capital firm that specializes in mid stage, bridge, and PIPE investments. The company invests in businesses which are at a phase of transforming from a research and development project to a full scale company. The firm seeks to invest in technology and consumer technologies companies based inIsrael. Aviv Venture Capital was founded by Amir Guttman in 2001 and is headquartered in Petach Tikva, Israel.
Aviv Venture Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Yoav Chelouche
Managing Partner
|
|||
Amir Guttman
Founder & Managing Partner
|
|||
Dov Tadmor
Chairman of the Investment Committee
|
|||
Gideon Y. Ben-Zvi
Venture Partner
|
|||
Sophie Caspi
CFO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Yoav Chelouche invest in?
Yoav Chelouche invests primarily in Sports, Medical and Wellness startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Yoav Chelouche?
Public channels for Yoav Chelouche include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Yoav Chelouche last invest?
The most recent investment recorded for Yoav Chelouche closed in Nov 2014. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
